1Ohishi T,Saito H,Tsusaka K. Antifibrogemic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachlorideinduced heptic fibrosis in rats[J].Heptol Res,2001,(02):147-158.
4Ide M,Yamale J,Machida Y. Emergence of different macrophage populations in hepatic fibrosis following hioacetamideinduced acute hepatocyte injury in rats[J].Journal of Comparative Pathology,2003,(01):41-51.doi:10.1053/jcpa.2002.0603.
5Constandinou C,Henderson N,Iredale JP. Modeling liver fibrosis in rodents[J].Methods in Molecular Medicine,2005.237-250.
6Li X,Benjamin IS,Alexander B. Reproducible production of thioacetamideinduced macronodular cirrhosis in the rat with no mortality[J].Journal of Hepatology,2002,(04):488-493.doi:10.1016/S0168-8278(02)00011-9.
7Luo B,Liu L,Tang L. ET1 and TNFalpha in HPS:analysis in prehepatic portal hypertension and biliary and no nbil iar y c irrh osi s in ra ts[J].Am J P hysi ol Gastrointest Liver Physiol,2004,(02):G294-G303.
10Buergener FA,Gutierrez OH,Logsdon GA. Angiographic,hemodynamic,and hitologic evaluation of portal hypertension and periportal fibrosis induced in the dog by intraportal polyvinyl alcohol injections[J].Radiology,1982,(02):379-385.